Oak Associates’s Elevance Health ELV Stock Holding History

Oak Associates’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$601K	Sell	2,054 -2,210	-52%	-$726K	0.04%	106
2025 Q4	$1.49M	Sell	4,264 -94	-2%	-$31.8K	0.09%	85
2025 Q3	$1.41M	Sell	4,358 -475	-10%	-$148K	0.09%	90
2025 Q2	$1.88M	Hold	4,833	–	–	0.12%	74
2025 Q1	$2.1M	Hold	4,833	–	–	0.16%	71
2024 Q4	$1.78M	Hold	4,833	–	–	0.12%	83
2024 Q3	$2.51M	Hold	4,833	–	–	0.17%	64
2024 Q2	$2.62M	Hold	4,833	–	–	0.17%	63
2024 Q1	$2.51M	Hold	4,833	–	–	0.17%	65
2023 Q4	$2.28M	Buy	4,833 +507	+12%	+$234K	0.17%	67
2023 Q3	$1.88M	Buy	4,326 +144	+3%	+$65.3K	0.16%	75
2023 Q2	$1.86M	Sell	4,182 -5	-0.1%	-$2.31K	0.15%	79
2023 Q1	$1.93M	Sell	4,187 -1,821	-30%	-$867K	0.16%	83
2022 Q4	$3.08M	Sell	6,008 -869	-13%	-$441K	0.26%	60
2022 Q3	$3.12M	Hold	6,877	–	–	0.27%	56
2022 Q2	$3.32M	Hold	6,877	–	–	0.26%	55
2022 Q1	$3.38M	Hold	6,877	–	–	0.21%	59
2021 Q4	$3.19M	Sell	6,877 -153	-2%	-$64.4K	0.17%	66
2021 Q3	$2.62M	Hold	7,030	–	–	0.15%	67
2021 Q2	$2.68M	Sell	7,030 -130	-2%	-$49.7K	0.15%	68
2021 Q1	$2.57M	Buy	7,160 +5	+0.1%	+$1.61K	0.15%	72
2020 Q4	$2.3M	Hold	7,155	–	–	0.14%	73
2020 Q3	$1.92M	Hold	7,155	–	–	0.13%	71
2020 Q2	$1.88M	Buy	7,155 +5,415	+311%	+$1.44M	0.13%	72
2020 Q1	$395K	Hold	1,740	–	–	0.03%	106
2019 Q4	$526K	Hold	1,740	–	–	0.03%	121
2019 Q3	$418K	Hold	1,740	–	–	0.03%	129
2019 Q2	$491K	Hold	1,740	–	–	0.03%	125
2019 Q1	$499K	Sell	1,740 -8,420	-83%	-$2.44M	0.03%	129
2018 Q4	$2.67M	Sell	10,160 -5,670	-36%	-$1.56M	0.19%	76
2018 Q3	$4.34M	Sell	15,830 -6,170	-28%	-$1.6M	0.27%	70
2018 Q2	$5.24M	Sell	22,000 -590	-3%	-$137K	0.35%	64
2018 Q1	$4.96M	Sell	22,590 -1,310	-5%	-$308K	0.35%	64
2017 Q4	$5.38M	Sell	23,900 -400	-2%	-$85.2K	0.38%	60
2017 Q3	$4.61M	Hold	24,300	–	–	0.34%	65
2017 Q2	$4.57M	Hold	24,300	–	–	0.34%	69
2017 Q1	$4.02M	Hold	24,300	–	–	0.32%	73
2016 Q4	$3.49M	Hold	24,300	–	–	0.34%	68
2016 Q3	$2.96M	Hold	24,300	–	–	0.31%	73
2016 Q2	$3.19M	Buy	24,300 +1,600	+7%	+$219K	0.38%	65
2016 Q1	$3.15M	Hold	22,700	–	–	0.39%	62
2015 Q4	$3.17M	Hold	22,700	–	–	0.38%	58
2015 Q3	$3.18M	Hold	22,700	–	–	0.42%	51
2015 Q2	$3.73M	Hold	22,700	–	–	0.45%	48
2015 Q1	$3.5M	Hold	22,700	–	–	0.42%	55
2014 Q4	$2.85M	Hold	22,700	–	–	0.34%	64
2014 Q3	$2.71M	Hold	22,700	–	–	0.33%	66
2014 Q2	$2.44M	Hold	22,700	–	–	0.3%	73
2014 Q1	$2.26M	Hold	22,700	–	–	0.28%	76
2013 Q4	$2.1M	Buy	+22,700	New	+$2.02M	0.23%	79
2013 Q2	$1.86M	Buy	+22,700	New	+$1.7M	0.22%	77

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Oak Associates's ELV Position: Q1 2026 in Review

Oak Associates reduced its Elevance Health (ELV) stake by 52% in Q1 2026, selling an estimated $726K and leaving 2,054 shares worth $601K. The position accounts for 0.04% of the portfolio, ranked #106.

Oak Associates first reported a position in ELV in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.38M in Q4 2017. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Oak Associates held 2,054 shares of Elevance Health worth $601K as of Q1 2026.
Oak Associates sold 2,210 Elevance Health shares in Q1 2026, an estimated $726K.
Elevance Health made up 0.04% of Oak Associates's portfolio in Q1 2026, its #106 holding.
Oak Associates first reported a position in Elevance Health in Q2 2013 and has held it in 51 quarters since.
Oak Associates's Elevance Health position peaked at $5.38M in Q4 2017.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Oak Associates's 13F filing for Q1 2026, filed 14 May 2026.